205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.79%
Revenue growth above 1.5x ON's 10.74%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
39.45%
Gross profit growth above 1.5x ON's 23.28%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
272.17%
EBIT growth 50-75% of ON's 397.83%. Martin Whitman would suspect suboptimal resource allocation.
3330.00%
Operating income growth above 1.5x ON's 397.83%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1429.41%
Net income growth above 1.5x ON's 91.15%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2000.00%
EPS growth above 1.5x ON's 91.34%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1900.00%
Diluted EPS growth above 1.5x ON's 91.34%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.63%
Share reduction while ON is at 1.72%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.39%
Reduced diluted shares while ON is at 1.72%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.80%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
121.91%
OCF growth 1.25-1.5x ON's 103.14%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
144.71%
FCF growth under 50% of ON's 581.25%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
29.78%
Positive 10Y revenue/share CAGR while ON is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
5.55%
Positive 5Y CAGR while ON is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-18.54%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
128.04%
Positive long-term OCF/share growth while ON is negative. John Neff would see a structural advantage in sustained cash generation.
53.26%
Positive OCF/share growth while ON is negative. John Neff might see a comparative advantage in operational cash viability.
6.84%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
-0.33%
Negative 10Y net income/share CAGR while ON is at 42.95%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-17.92%
Negative 5Y net income/share CAGR while ON is 48.39%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-86.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
73.41%
10Y equity/share CAGR above 1.5x ON's 13.45%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
3.13%
Below 50% of ON's 209.60%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-11.69%
Negative 3Y equity/share growth while ON is at 752.12%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
417.19%
Dividend/share CAGR of 417.19% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
423.04%
Stable or rising mid-term dividends while ON is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
262.50%
Our short-term dividend growth is positive while ON cut theirs. John Neff views it as a comparative advantage in shareholder returns.
10.58%
AR growth is negative/stable vs. ON's 31.93%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.19%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.09%
Negative asset growth while ON invests at 0.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.66%
1.25-1.5x ON's 0.58%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
-4.40%
Our R&D shrinks while ON invests at 16.28%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.21%
SG&A growth well above ON's 3.73%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.